Millions of breast cancer patients could safely avoid chemotherapy, study suggests - BBC
An international study suggests that millions of breast cancer patients could safely avoid chemotherapy thanks to a new DNA test, Prosigna, which identifies those unlikely to benefit from the treatment. This allows over two-thirds of participants to be treated with hormone therapy alone, maintaining high five-year survival rates and sparing them severe side effects.
Why it matters
This research has significant implications for breast cancer treatment, potentially improving the quality of life for countless patients by reducing unnecessary chemotherapy and its debilitating side effects, while also optimizing healthcare resources globally.
Millions of breast cancer patients could safely avoid chemotherapy, study suggests
The article reports on a scientific study, presenting its findings, methodology, and implications in a straightforward, objective manner, quoting researchers and a patient.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in